Improving outcome for scirrhous gastric cancer

Gastric Cancer

Volumn 12, Issue 1, 2009, Pages 3-5

  Hartgrink, H H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ANTHRACYCLINE; CAPECITABINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; OXALIPLATIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFICACY; DRUG SUBSTITUTION; EDITORIAL; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCIRRHOUS GASTRIC CANCER; STOMACH CANCER;

ADENOCARCINOMA, SCIRRHOUS; HUMANS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 65449136695     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-009-0501-3     Document Type: Editorial

References (19)

1. Japanese Gastric Cancer Association Registration Committee K. Maruyama M. Kaminishi K. Hayashi Y. Isobe I. Honda 2006 Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry Gastric Cancer 9 51 66 (Pubitemid 43890701)
2. C. Liu R.M. Russell 2008 Nutrition and gastric cancer risk: an update Nutr Rev 66 237 249
3. N. Uemura S. Okamoto S. Yamamoto N. Matsumura S. Yamaguchi M. Yamakido 2001 Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 784 789
4. L. Fuccio R.M. Zagari M.E. Minardi F. Bazzoli 2007 Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer Aliment Pharmacol Ther 25 133 141 (Pubitemid 46046370)
5. K. Fukase M. Kato S. Kikuchi K. Inoue N. Uemura S. Okamota 2008 Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 392 397
6. F. Kamangar G.M. Dores W.F. Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150 (Pubitemid 46655601)
7. H.H. Hartgrink C.J. van de Velde H. Putter J.J. Bonenkamp E. Klein Kranenbarg I. Songun 2004 Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 2069 206977 (Pubitemid 41095139)
8. A. Cuschieri S. Weeden J. Fielding J. Bancewicz J. Craven V. Joypaul 1999 Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group Br J Cancer 79 1522 1530 (Pubitemid 29116815)
9. C.W. Wu C.A. Hsiung S.S. Lo M.C. Hsich J.H. Chen A.F. Li 2006 Nodal dissection for patients with gastric cancer: a randomised controlled trial Lancet Oncol 7 309 315
10. M. Sasako T. Sano S. Yamamoto Y. Kurakawa A. Nashimoto A. Kurita 2008 D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 453 462
11. F. Fiorica F. Cartei M. Enea A. Licata G. Cabibbo B. Carau 2007 The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data Cancer Treat Rev 33 729 740 (Pubitemid 350082668)
12. J.S. Macdonald S.R. Smalley J. Benedetti S.A. Hundahl N.C. Estes G.N. Stemmermann 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 30
13. S. Kim D.H. Lim J. Lee W.K. Kang J.S. Macdonald C.H. Park 2005 An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 63 1279 1285 (Pubitemid 41628018)
14. D. Cunningham W.H. Allum S.P. Stenning J.N. Thompson C.J. van de Velde M. Nicolson 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20
15. H.H. Hartgrink C.J. van de Velde H. Putter I. Songun M.E. Tesselaar E. Klein Kranenbarg 2004 Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial Eur J Surg Oncol 30 643 649 (Pubitemid 39060735)
16. V. Boige J. Pignon B. Saint-Aubert T. Lasser O. Conroy P. Bouche 2007 Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial Proc Am Soc Clin Oncol 25 A4510
17. S. Sakuramoto M. Sasako T. Yamaguchi T. Kinoshita M. Fujii A. Nashimoto 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820 (Pubitemid 350044801)
18. T. Kinoshita M. Sasako T. Sano H. Katai H. Furukawa A. Tsuburaya 2009 Phase II trial of TS-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG0002) Gastric Cancer 12 37 42
19. T.D. Yan D. Black P.H. Sugarbaker J. Zhu Y. Yonemura G. Petrou 2007 A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer Ann Surg Oncol 14 2702 2713 (Pubitemid 47460649)